Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
8/31/2023
Recent Official and Executive Moves
8/31/2023
MC2 Thera and Huadong Pharma Enter LIcense Deal for Plague Psoriasis D...
8/31/2023
NHSA to Cancel Hospital Payment Rights for Drug and Consumable Procure...
8/31/2023
NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
8/31/2023
IQVIA: Chinese Retail Pharmacy Sales up 8.9% in MAT Q2/2023
8/30/2023
CDE Publicizes the List of Reference Formulations for GQCE Studies (73...
8/30/2023
Review of Rising Sales Expenditures Trend of A and H Share-Listed Chin...
8/30/2023
Upcoming Event: 15th Annual Pharma Market Research Conference
(Free)
8/30/2023
Upcoming Event: 2023 Pharma CI USA Conference & Exhibition
(Free)
8/29/2023
CanSino to Acquire 10% Stake in Malaysian Vaccine Maker Solution
8/29/2023
NMPA Set to Raise the Bar for Conditional Approval Process of New Drug...
8/29/2023
Former Star Official of China's Healthcare Reform and VBP Architect ...
8/29/2023
NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
8/29/2023
NMPA Announces Package Insert Revision of Two Drug Products
8/28/2023
Chinese Pharma CEOs Emphasize Strategic R&D Selection in Tough Fundrai...
8/28/2023
CDE Solicits Second Round Comments on Two Pharmaceutical Change Resear...
8/28/2023
Verastem Oncology Enters Partnerships with GenFleet Therapeutics to Ad...
8/25/2023
Drug R&D and Product Registration News Digest August 2023 (4)
8/25/2023
State Council Adopts New Action Plan for High-quality Development of P...
8/25/2023
IQVIA: Overall Chinese Pharma Market Growth Up 0.3% in 2022
8/25/2023
Domestic Pharma Sealed Ten Outlicensing Deals in H1/2023 (Updated)
8/25/2023
NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...
8/25/2023
NMPA Issues Announcement for Applicability of ICH Guidelines Q12
8/25/2023
CDE Seeks Comments on Draft ICH Guidelines M7(R2)
8/24/2023
CMS Licenses China Rights of Class 1 Anti-Ischemic Stroke New Drug fro...
8/24/2023
Chinese Consortium Eyes Acquisition of Dominant Polish Pharma Distribu...
8/24/2023
Review of China Performance of Leading MNCs in China H1/2023 (Updated)
8/23/2023
Chinese and Indonesian Cos Form New Partnerships in Biotech & Healthca...
8/23/2023
NMPA Issues the List of Reference Formulations for GQCE Studies (72nd ...
8/23/2023
NMPA Appoints New Director General of the CDE
Page:
29
/
33
Total number of articles:
961
:
[First]
[<<]
[27]
[28]
[29]
[30]
[31]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit